These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20346127)

  • 41. An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.
    Feldman RM
    Expert Opin Pharmacother; 2004 Apr; 5(4):909-21. PubMed ID: 15102573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.
    Hamacher T; Schinzel M; Schölzel-Klatt A; Neff HM; Maier H; Schlaffer G; Beausencourt E; Jütte M; Scholz R; Lorger C; Stewart WC
    Br J Ophthalmol; 2004 Oct; 88(10):1295-8. PubMed ID: 15377554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Latanoprost: experience of 2-year treatment in Scandinavia.
    Alm A; Widengård I
    Acta Ophthalmol Scand; 2000 Feb; 78(1):71-6. PubMed ID: 10726794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
    Simmons ST; Samuelson TW
    Clin Ther; 2000 Apr; 22(4):388-99. PubMed ID: 10823361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.
    Alezzandrini A; Hubatsch D; Alfaro R
    Adv Ther; 2014 Sep; 31(9):975-85. PubMed ID: 25138224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database.
    Lazaridou MN; Montgomery DM; Ho WO; Jaberoo D
    Curr Med Res Opin; 2008 Oct; 24(10):2725-8. PubMed ID: 18713491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of latanoprost monotherapy with timolol-dorzolamide combination in patients with open-angle glaucoma or ocular hypertension].
    Bron A;
    J Fr Ophtalmol; 2002 Jun; 25(6):604-8. PubMed ID: 12223948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: A double-masked, randomized, one-year study.
    Lass JH; Eriksson GL; Osterling L; Simpson CV;
    Ophthalmology; 2001 Feb; 108(2):264-71. PubMed ID: 11158797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.
    Garcia-Medina JJ; Benitez-Del-Castillo J; Rodríguez-Agirretxe I; Lopez-Lopez F; Moreno-Valladares A;
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):252-260. PubMed ID: 35230148
    [No Abstract]   [Full Text] [Related]  

  • 52. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
    Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
    Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy.
    Holló G; Kirwan J; Lopez-Lopez F; Zimina M; Fassari C; Oddone F;
    Curr Med Res Opin; 2022 Jul; 38(7):1189-1201. PubMed ID: 35621005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study.
    Crichton AC; Harasymowycz P; Hutnik CM; Behki R; Boucher S; Ibrahim F; Rifkind AW; Solomon L; Liao C; Bastien NR; Sampalis JS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):503-11. PubMed ID: 20874498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
    Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
    J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
    Kobayashi H
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):387-91. PubMed ID: 22335426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.
    Uva MG; Longo A; Reibaldi M
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1103-9. PubMed ID: 19247684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study.
    Centofanti M; Oddone F; Vetrugno M; Manni G; Fogagnolo P; Tanga L; Ferreri P; Rossetti L
    Eur J Ophthalmol; 2009; 19(1):66-71. PubMed ID: 19123151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma.
    Honrubia FM; Larsson LI; Spiegel D;
    Acta Ophthalmol Scand; 2002 Dec; 80(6):635-41. PubMed ID: 12485286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.